What were the primary drivers of Stryker's sales growth in the first half of 2001?

Stryker's sales growth was primarily driven by increased unit volume (12%), higher selling prices (2%), revenue from acquired businesses (1%), and the inclusion of freight revenue in net sales (1%). This was partially offset by a 3% decline due to unfavorable foreign currency exchange rates.

What is the expected impact of the new accounting standards regarding goodwill?

The adoption of new FASB standards (Statement No. 142) starting in 2002 will eliminate the amortization of goodwill. Stryker estimates this change will reduce intangibles amortization by approximately $15 million and increase net earnings by about $10 million ($0.05 per diluted share) annually, though the company will conduct impairment tests for goodwill and intangible assets.

What is the company's liquidity and debt situation?

Stryker had $42.6 million in cash and cash equivalents at June 30, 2001. Total debt decreased by $128.9 million in the first half of 2001, and the company had $248.3 million of additional borrowing capacity available under its credit facilities. Management believes its current cash and anticipated operating cash flows are sufficient to meet future needs and debt obligations.

SYK 10-Q Quarterly Report Q2 FY2001 — Revenue, Net Income, EPS

Q: How did the Orthopaedic Implants and MedSurg Equipment segments perform?

The Orthopaedic Implants segment saw a 7% increase in sales for the first six months of 2001, while the MedSurg Equipment segment experienced a stronger 19% increase in sales during the same period. This indicates robust growth in the MedSurg division.

Summary

Stryker Corporation reported a solid increase in financial performance for the six months ended June 30, 2001, with net sales growing 13% to $1,273.2 million and net earnings increasing by 24% to $129.8 million. This growth was driven by strong domestic sales across both its Orthopaedic Implants and MedSurg Equipment segments, as well as increased revenue from Physical Therapy Services. The company demonstrated improved operational efficiency, with accounts receivable and inventory days on hand decreasing, contributing to a significant increase in cash provided by operating activities to $152.0 million. While international sales saw a slight decline due to unfavorable foreign currency exchange rates, underlying growth excluding currency impacts remained robust. The company is also anticipating a positive impact on earnings beginning in 2002 from the adoption of new accounting standards that will eliminate goodwill amortization, estimated to increase net earnings by approximately $10 million. Despite a notable increase in debt repayment during the period, Stryker maintains sufficient liquidity and borrowing capacity to fund future operations.

Key Highlights

1Net sales increased 13% to $1,273.2 million for the first six months of 2001, compared to $1,128.6 million in the prior year.
2Net earnings grew 24% to $129.8 million for the first six months of 2001, up from $104.5 million in the same period of 2000.
3Domestic sales showed strong growth of 21% for the first six months, while international sales remained relatively flat due to currency headwinds, though underlying growth was positive.
4The MedSurg Equipment segment experienced robust growth of 19% in net sales for the first six months, outpacing the Orthopaedic Implants segment's 7% growth.
5Cash provided by operating activities increased significantly by 39% to $152.0 million for the first six months of 2001.
6The company expects to adopt new accounting standards in 2002 that will eliminate goodwill amortization, potentially increasing net earnings by approximately $10 million annually.

STRYKER CORP Quarterly Report for Q2 Ended Jun 30, 2001

Summary

Key Highlights

Frequently Asked Questions